Company intelligence / Profile preview

Essilor

Charenton-le-Pont, Île-de-France, Franceessilor.com ↗

Ownership: Public · EL
Development stage: Commercial

Overview

Essilor was the world’s largest manufacturer of ophthalmic lenses and a global leader in vision care solutions. Its flagship products included Varilux progressive lenses and Crizal coatings. The company focused on innovation in lens technology for both corrective and protective purposes. In October 2018, it merged with Luxottica to form the industry giant EssilorLuxottica.

Therapeutic areas: Ophthalmology
Modalities: DeviceNon-pharmacological therapy
Industry: Assistive Medical Devices

Drug pipeline

1 asset

Stellest

Commercial

Indications: Myopia

Partnerships

Long-term collaborations with optometrists/ophthalmologists worldwidepost-merger partnerships include major fashion/luxury brands via Luxottica’s licensing deals.

Financials

Market cap: $34.9B
Total revenue: $3.6B
Enterprise value: $40.6B

Beyond the preview

Go deeper on Essilor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Essilor.

Explore the full profile